ChromaDex Furthers TRU NIAGEN® Global Expansion in Canada with WELL Health Technologies

NEXT STORY
The $6.5 Billion Biodefense Market by 2025 – Small Pox is Expected to Be the Fastest Growing Product Segment
PREV STORY
Novartis entame 2019 avec une forte croissance des ventes et une hausse à deux chiffres du résultat opérationnel core[1], le lancement de Mayzent et le spin-off d’Alcon; profit annuel revu à la hausse
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

BeyondSpring E-Poster Presented at 2020 ASCO Virtual Scientific Program

author_avatar
NASDAQ Market News

Primary endpoint met in COMET-TAIL Phase 3 trial evaluating intramuscular administration of sotrovimab for early treatment of COVID-19

author_avatar
NASDAQ Market News

Adaptive Announces Preliminary Unaudited Revenue for Full Year 2019

author_avatar
NASDAQ Market News